Dr. Reddy's Laboratories Ltd. Financials: Quarterly Results
Revenue
9028.1
Cr.
PAT
1581.20
Cr.
EBITDA
2065.30
Cr.
Dr. Reddy's Laboratories Ltd. Q4FY25 Financial Metrics
| Indicator | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 8506 | 8381.20 | 8038.20 | 7696.10 | 7083 |
| Total Income From Operations (Cr.) | 8528.40 | 8381.20 | 8038.20 | 7696.10 | 7113.80 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 2065.30 | 1951.80 | 1987 | 1936.50 | 1661 |
| P/L Before Exceptional Items & Tax (Cr.) | 1999.70 | 1870.10 | 1911.30 | 1876.70 | 1601.70 |
| P/L After Tax from Ordinary Activities (Cr.) | 1581.20 | 1400 | 1335.80 | 1386.50 | 1306.30 |
| Net Profit/Loss For the Period (Cr.) | 1581.20 | 1400 | 1335.80 | 1386.50 | 1306.30 |
| Basic EPS | 19.12 | 16.97 | 80.45 | 83.61 | 78.66 |
FAQs
Dr. Reddy's Laboratories Ltd. announced its quarterly results for Q4 FY2025 on May 9, 2025.
In Q4 FY2025, Dr. Reddy's Laboratories Ltd. are as follows:
Revenue: ₹9028.1 crore
Net Profit: ₹1581.20 crore.
For Q4 FY2025, Dr. Reddy's Laboratories Ltd. posted ₹9028.1 crore in revenue and ₹1581.20 crore in net profit.
Past quarterly results for Dr. Reddy's Laboratories Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.